Prostacyclin, thromboxane A2, and atherosclerosis in young hypercholesterolemic swine.
Plasma 6-keto-prostaglandin F1 alpha and thromboxane B2 levels were determined to evaluate their role as predictive indicators for the development and progression of coronary atherosclerosis in young hypercholesterolemic swine. 32 young swine were randomly assigned to the control or atherogenic diet group for 10, 30, 90, or 180 days. Lipid profiles were obtained at the onset and repeated throughout the study. Radioimmunoassays of plasma 6-keto-prostaglandin F1 alpha and thromboxane B2 were recorded at 10 day intervals in the 10 and 30 day subjects and at 30 day intervals in the 90 and 180 day subjects. Sections from the proximal left anterior descending coronary artery were classified based on their histological evidence of atherosclerosis by light microscopy. Hypercholesterolemia was positively correlated with development of coronary atherosclerosis (r = 0.704). However, plasma 6-keto-prostaglandin F1 alpha, thromboxane B2, and the thromboxane B2:6-keto-prostaglandin F1 alpha ratio were not found to be predictive indicators (p > 0.05) for the development or early progression of coronary atherosclerosis.
Department of Physiology, Colorado State University, Fort Collins 80523.
J F
JF
Norman
C W
CW
Miller
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D001835:Body Weight; D004036:Diet, Atherogenic; D004195:Disease Models, Animal; D011464:Epoprostenol / Q000097:blood*; D005260:Female; D006400:Hematocrit; D006937:Hypercholesterolemia / Q000097:blood* / Q000150:complications* / Q000473:pathology; D008055:Lipids / Q000097:blood; D008297:Male; D011897:Random Allocation; D012307:Risk Factors; D013552:Swine; D013928:Thromboxane A2 / Q000097:blood*; D013929:Thromboxane B2 / Q000097:blood
D008055:Lipids; D013929:Thromboxane B2; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol